Literature DB >> 26546566

Pediatric schwannomatosis, a rare but distinct form of neurofibromatosis.

Anna K Thomas1, John C Egelhoff2, John G Curran2, Bobby Thomas3.   

Abstract

Schwannomatosis is the third major form of neurofibromatosis, distinct from neurofibromatosis type 2 (NF2) and type 1 (NF1). This condition is rare with a variable phenotypic presentation and complex molecular and genetic findings. In this case, a previously healthy teenager was found to have multiple spinal lesions and an enhancing right parotid mass on MRI. On extensive further work-up, this patient met the existing clinical criteria for schwannomatosis. This case report aims to review the clinical features and current diagnostic criteria for schwannomatosis and compare it to NF1 and NF2. Special emphasis will be placed on imaging features that should prompt the radiologist to suggest this rare diagnosis.

Entities:  

Keywords:  Adolescent; Magnetic resonance imaging; Neurofibromatosis; Schwannomatosis; Spinal cord; Spine

Mesh:

Year:  2015        PMID: 26546566     DOI: 10.1007/s00247-015-3482-x

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  8 in total

1.  Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.

Authors:  Scott R Plotkin; Jaishri O Blakeley; D Gareth Evans; C Oliver Hanemann; Theo J M Hulsebos; Kim Hunter-Schaedle; Ganjam V Kalpana; Bruce Korf; Ludwine Messiaen; Laura Papi; Nancy Ratner; Larry S Sherman; Miriam J Smith; Anat O Stemmer-Rachamimov; Jeremie Vitte; Marco Giovannini
Journal:  Am J Med Genet A       Date:  2013-02-07       Impact factor: 2.802

Review 2.  Diagnostic criteria for schwannomatosis.

Authors:  M MacCollin; E A Chiocca; D G Evans; J M Friedman; R Horvitz; D Jaramillo; M Lev; V F Mautner; M Niimura; S R Plotkin; C N Sang; A Stemmer-Rachamimov; E S Roach
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

Review 3.  Schwannomatosis: a clinical and pathologic study.

Authors:  M MacCollin; W Woodfin; D Kronn; M P Short
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

4.  Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.

Authors:  Katherine W Eaton; Laura S Tooke; Luanne M Wainwright; Alexander R Judkins; Jaclyn A Biegel
Journal:  Pediatr Blood Cancer       Date:  2011-01       Impact factor: 3.167

5.  Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas.

Authors:  Arkadiusz Piotrowski; Jing Xie; Ying F Liu; Andrzej B Poplawski; Alicia R Gomes; Piotr Madanecki; Chuanhua Fu; Michael R Crowley; David K Crossman; Linlea Armstrong; Dusica Babovic-Vuksanovic; Amanda Bergner; Jaishri O Blakeley; Andrea L Blumenthal; Molly S Daniels; Howard Feit; Kathy Gardner; Stephanie Hurst; Christine Kobelka; Chung Lee; Rebecca Nagy; Katherine A Rauen; John M Slopis; Pim Suwannarat; Judith A Westman; Andrea Zanko; Bruce R Korf; Ludwine M Messiaen
Journal:  Nat Genet       Date:  2013-12-22       Impact factor: 38.330

Review 6.  Schwannomatosis: the overlooked neurofibromatosis?

Authors:  Nicholas A Koontz; Andrea L Wiens; Atul Agarwal; Cynthia M Hingtgen; Robert E Emerson; Kristine M Mosier
Journal:  AJR Am J Roentgenol       Date:  2013-06       Impact factor: 3.959

7.  Clinical features of schwannomatosis: a retrospective analysis of 87 patients.

Authors:  Vanessa L Merker; Sonia Esparza; Miriam J Smith; Anat Stemmer-Rachamimov; Scott R Plotkin
Journal:  Oncologist       Date:  2012-08-27

8.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.

Authors:  I Versteege; N Sévenet; J Lange; M F Rousseau-Merck; P Ambros; R Handgretinger; A Aurias; O Delattre
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962

  8 in total
  1 in total

1.  Surgical management of peripheral nerve sheath tumours in children, with special consideration of neurofibromatoses.

Authors:  Julian Zipfel; Meizer Al-Hariri; Isabel Gugel; Karin Haas-Lude; Alexander Grimm; Steven Warmann; Michael Krimmel; Victor-Felix Mautner; Marcos Tatagiba; Martin U Schuhmann
Journal:  Childs Nerv Syst       Date:  2020-06-06       Impact factor: 1.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.